Dr Steve Burnell: Ledger

Stories naming Dr Steve Burnell. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.

Role	Organisation	Sources
Executive (former)	Roche Group	Business News Australia, Brandon Capital portfolio, Brandon BioCatalyst portfolio
Managing Director	Tenmile	-

2 deals

Billionaires Andrew and Nicola Forrest take aim at peanut allergy

Biotech Aravax has received a US$20 million Series B commitment from Brandon Capital and Tenmile to advance its peanut allergy therapy PVX108 into Phase 2 trials.

Brandon BioCatalyst portfolio 20 Dec 2022 Aravax Tenmile Carina Biotech Emyria Psylo Roche Group Rock Health Tattarang Brandon Capital Dr Andrew Forrest Dr Chris Smith Dr Dr Steve Burnell Nicola Forrest Dr Pascal Hickey Dr Steve Burnell

Also Brandon Capital portfolio·Startup Daily·Startup News (WA)·Techboard·Startup Daily

Dr Steve Burnell

Roles

Coverage

Billionaires Andrew and Nicola Forrest take aim at peanut allergy